| Biomarker threshold adaptive designs for survival endpoints G Diao, J Dong, D Zeng, C Ke, A Rong, JG Ibrahim Journal of biopharmaceutical statistics 28 (6), 1038-1054, 2018 | 11 | 2018 |
| Clinical validation of the next-generation sequencing-based Extended RAS Panel assay using metastatic colorectal cancer patient samples from the phase 3 PRIME study N Udar, C Lofton-Day, J Dong, D Vavrek, AS Jung, K Meier, A Iyer, ... Journal of Cancer Research and Clinical Oncology 144, 2001-2010, 2018 | 27 | 2018 |
| Validation of a Next-Generation Sequencing-Based Assay to Detect Extended RAS Mutations in FFPE Samples for Identification of Metastatic Colorectal Cancer Patients Eligible for … N Udar, C Lofton-Day, J Dong, D Vavrek, K Meier, A Jung, A Iyer, ... JOURNAL OF MOLECULAR DIAGNOSTICS 19 (6), 1056-1056, 2017 | | 2017 |
| Pattern mixture models for clinical validation of biomarkers in the presence of missing data F Gao, J Dong, D Zeng, A Rong, JG Ibrahim Statistics in medicine 36 (19), 2994-3004, 2017 | 2 | 2017 |
| A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer TW Kim, A Elme, Z Kusic, JO Park, AA Udrea, SY Kim, JB Ahn, ... British journal of cancer 115 (10), 1206-1214, 2016 | 64 | 2016 |
| PARTNER: An open-label, randomized, phase 2 study of docetaxel/cisplatin chemotherapy with or without panitumumab as first-line treatment for recurrent or metastatic squamous … LJ Wirth, S Dakhil, G Kornek, R Axelrod, D Adkins, S Pant, P O’Brien, ... Oral oncology 61, 31-40, 2016 | 22 | 2016 |
| A two-step estimation approach for logistic varying coefficient modeling of longitudinal data J Dong, JP Estes, G Li, D Şentürk Journal of statistical planning and inference 174, 38-51, 2016 | 5 | 2016 |
| Q-TWiST analysis of panitumumab plus FOLFOX4 versus FOLFOX4 alone in patients with previously untreated wild-type RAS metastatic colorectal cancer J Wang, G Hechmati, J Dong, GA Maglinte, B Barber, JY Douillard Current Medical Research and Opinion 32 (3), 459-465, 2016 | 7 | 2016 |
| The PRIME trial: Quality-adjusted survival in patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC) receiving first-line therapy with panitumumab … J Wang, J Dong, G Hechmati, A Rong, G Maglinte, BL Barber, ... Journal of Clinical Oncology 33 (15_suppl), 3543-3543, 2015 | 3 | 2015 |
| Assessing temporal agreement between central and local progression‐free survival times D Zeng, E Cornea, J Dong, J Pan, JG Ibrahim Statistics in medicine 34 (5), 844-858, 2015 | 1 | 2015 |
| A Two-step Estimation Approach for Logistic Varying Coefficient Modeling of Longitudinal G Li, D Senturk, J Dong | | 2015 |
| A Two-step Estimation Approach for Logistic Varying Coefficient Modeling of Longitudinal Data G Li, D Senturk, J Dong, JP Estes | | 2015 |
| Genomic landscape of meningiomas Y Lee, J Liu, S Patel, T Cloughesy, A Lai, H Farooqi, D Seligson, J Dong, ... Brain pathology 20 (4), 751-762, 2010 | 164 | 2010 |
| Weighted gene coexpression network analysis: state of the art W Zhao, P Langfelder, T Fuller, J Dong, A Li, S Hovarth Journal of biopharmaceutical statistics 20 (2), 281-300, 2010 | 376 | 2010 |
| Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone M Kappadakunnel, A Eskin, J Dong, SF Nelson, PS Mischel, LM Liau, ... Journal of neuro-oncology 96, 359-367, 2010 | 108 | 2010 |
| Predictor model of root caries in older adults: reporting of evidence to the translational evidence mechanism JG Bauer, S Spackman, J Dong, N Garrett The open dentistry journal 4, 124, 2010 | 5 | 2010 |
| Disease gene characterization through large-scale co-expression analysis A Day, J Dong, VA Funari, B Harry, SP Strom, DH Cohn, SF Nelson PloS one 4 (12), e8491, 2009 | 44 | 2009 |
| Weighted gene co-expression network analysis identifies biomarkers in glycerol kinase deficient mice NK MacLennan, J Dong, JE Aten, S Horvath, L Rahib, L Ornelas, ... Molecular genetics and metabolism 98 (1-2), 203-214, 2009 | 46 | 2009 |
| Genetically defined EWS/FLI1 model system suggests mesenchymal origin of Ewing's family tumors G Potikyan, KA France, MRJ Carlson, J Dong, SF Nelson, CT Denny Laboratory investigation 88 (12), 1291-1302, 2008 | 39 | 2008 |
| Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age Y Lee, AC Scheck, TF Cloughesy, A Lai, J Dong, HK Farooqi, LM Liau, ... BMC medical genomics 1, 1-12, 2008 | 227 | 2008 |
Stan NelsonProfessor of Human Genetics, UCLA在 ucla.edu 的电子邮件经过验证
